Legora
Legora Raises $550M Series E at $8.8B Valuation
Legora announced $550M in Series E financing on October 21, 2026. Legora raised a $550 million Series E at an $8.8 billion post-money valuation, led by Atreides Management.
Round details
The financing includes backing from Atreides Management, Baron Capital, Capital Group, Fidelity Management and Research Company, Glade Brook Capital Partners, J.P. Morgan, Accel, Benchmark. The company reported a $8.8B valuation alongside the transaction.
- Round: Series E
- Capital announced: $550M
How the company plans to use the capital
Legora said the capital will support continued expansion in North America and in its markets across Europe and Asia-Pacific. It will also deepen investment in the Legora aOS, its agentic operating system, to bring new products such as agentic intake, horizon scanning and legal research to life.
Why this matters for GTM teams
Every major existing investor took part in the round alongside new investors, and the $8.8 billion post-money valuation compares with $5.6 billion at the company’s previous round, according to Legora.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Legora Series E announcement.
Company Info
Investors (8)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


